Biological and Pharmaceutical Bulletin
Online ISSN : 1347-5215
Print ISSN : 0918-6158
ISSN-L : 0918-6158
Errata
Errata for Biological and Pharmaceutical Bulletin
JOURNAL OPEN ACCESS FULL-TEXT HTML

2026 Volume 49 Issue 2 Pages 400

Details

Errata for Biological and Pharmaceutical Bulletin

Vol.PageLineErrorCorrection
481911Summary Line 9reducing the residual rates of tacrolimus and everolimus by 8 and 17%, respectively, in vitro.reducing the residual rates of tacrolimus and everolimus to 17 and 21% of the control, respectively, in vitro.
1915Left 3reduced by 17 and 21%,reduced to 17 and 21% of the control,
Left 20reduced by 7, 5, and 10%,reduced to 7, 5, and 10% of control,
Left 21reduced by 10, 9, and 30%.reduced to 10, 9, and 30% of control.
1916Left 4reduced tacrolimus residuals by 34–47%,reduced tacrolimus residuals to 34–47%,
Left 5reduced them by 37–52%.reduced them to 37–52%.
 
© 2026 The Author(s).
Published by The Pharmaceutical Society of Japan

This article is licensed under a Creative Commons [Attribution-NonCommercial 4.0 International] license.
https://creativecommons.org/licenses/by-nc/4.0/
feedback
Top